Lung disease mystery: 1500 patients to be tracked for clues
NCT ID NCT05810493
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study follows 1500 adults with interstitial lung disease to understand how the condition changes over time. Researchers will track symptoms, lung function, and treatments used. The goal is to build a detailed picture of the disease's course and improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how interstitial lung disease progresses and which treatments work best for different patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not directly test any new therapy. Results may take years to influence patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Nice
Nice, 06200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI catch lung scarring that doctors might miss?
- Can arm workouts boost oxygen use in lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
- AI outruns radiologists in detecting early lung scarring
- Smart home tech could help lung patients breathe easier at home